Year archive

Pharmala Biotech Holdings Inc. — 2025 filings

All 71 regulatory filings released by Pharmala Biotech Holdings Inc. (MDMA) in 2025, sourced directly from the official regulator.

71 Filings

2025 Period

2025 filings (71)

Filing	Released	Lang
News release - English.pdf Report Publication Announcement	2025-12-24	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2026	2025-12-24	English
Interim MD&A - English.pdf Management Reports	2025-12-24	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings Q1 2025	2025-12-24	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings Q1 2026	2025-12-24	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Capital/Financing Update	2025-12-24	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Audit Report / Information FY 2025	2025-12-24	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-12-24	English
Annual MD&A - English.pdf Management Reports	2025-12-24	English
News release - English.pdf Regulatory Filings	2025-12-15	English
News release - English.pdf Regulatory Filings	2025-12-10	English
Material change report - English.pdf Regulatory Filings	2025-11-10	English
News release - English.pdf Regulatory Filings	2025-11-03	English
Decision Document (Final).pdf Regulatory Filings	2025-10-31	English
Auditors' consent letter.pdf Regulatory Filings	2025-10-31	English
Consent letter of issuer's legal counsel.pdf Regulatory Filings	2025-10-30	English
Material change report - English.pdf Regulatory Filings	2025-10-09	English
News release - English.pdf Board/Management Information	2025-10-08	English
News release - English.pdf Regulatory Filings	2025-10-02	English
News release - English.pdf Board/Management Information	2025-09-25	English
News release - English.pdf Capital/Financing Update	2025-09-19	English
Decision Document (Amendment to Preliminary).pdf Regulatory Filings	2025-09-18	English
Amendment to (or amended) preliminary short form prospectus – English.pdf Capital/Financing Update	2025-09-18	English
Material change report - English.pdf Regulatory Filings	2025-09-12	English
News release - English.pdf Board/Management Information	2025-09-08	English
News release - English.pdf Regulatory Filings	2025-09-03	English
News release - English.pdf Regulatory Filings	2025-08-07	English
News release - English.pdf Earnings Release Q3 2025	2025-07-25	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-07-25	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-07-25	English
Interim MD&A - English.pdf Management Reports	2025-07-25	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q4 2025	2025-07-25	English
Material change report - English.pdf Capital/Financing Update	2025-06-30	English
News release - English.pdf Capital/Financing Update	2025-06-20	English
Decision Document (Preliminary).pdf Regulatory Filings	2025-06-20	English
Preliminary short form prospectus – English.pdf Regulatory Filings	2025-06-20	English
Decision Document / Order for Application - French.pdf Regulatory Filings	2025-06-20	French
News release - English.pdf Regulatory Filings	2025-06-03	English
News release - English.pdf Regulatory Filings	2025-06-03	English
News release - English.pdf Regulatory Filings	2025-06-03	English
News release - English.pdf Regulatory Filings	2025-06-03	English
News release - English.pdf Regulatory Filings	2025-05-30	English
News release - English.pdf Regulatory Filings	2025-05-15	English
52-109F1-AIF - Certification of filings with voluntarily filed AIF - CEO(E).pdf Regulatory Filings	2025-05-14	English
Annual information form - English.pdf Regulatory Filings	2025-05-14	English
Material change report - English.pdf Regulatory Filings	2025-05-09	English
News release - English.pdf Regulatory Filings	2025-04-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-04-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-04-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report H1 2025	2025-04-29	English
Interim MD&A - English.pdf Management Reports	2025-04-29	English
News release - English.pdf Regulatory Filings	2025-03-24	English
News release - English.pdf Regulatory Filings	2025-03-21	English
News release - English.pdf Regulatory Filings	2025-03-10	English
News release - English.pdf Regulatory Filings	2025-03-03	English
News release - English.pdf Regulatory Filings	2025-02-27	English
Management information circular - English.pdf Proxy Solicitation & Information Statement	2025-02-26	English
Other.pdf Proxy Solicitation & Information Statement	2025-02-26	English
Other.pdf Report Publication Announcement	2025-02-26	English
Other.pdf Proxy Solicitation & Information Statement	2025-02-26	English
Notice of meeting - English.pdf Proxy Solicitation & Information Statement	2025-02-26	English
Form of proxy - English.pdf Proxy Solicitation & Information Statement	2025-02-26	English
News release - English.pdf Board/Management Information	2025-02-06	English
News release - English.pdf Earnings Release Q1 2025	2025-01-29	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-01-29	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-01-29	English
Interim MD&A - English.pdf Management Reports	2025-01-29	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-01-29	English
News release - English.pdf M&A Activity	2025-01-20	English
Notice of the meeting and record date - English.pdf Capital/Financing Update	2025-01-17	English
Notice of the meeting and record date - English.pdf Proxy Solicitation & Information Statement	2025-01-17	English